top of page


A versatile bioink for printing human tissue models 

Our bioink reduces the time and labor costs for drug development 


Our bioink is always quality control tested for consistency, reproducibility, and sterility​

pink quality.png

Our bioinks can support a variety of specialized cell types and have associated protocols that are optimized for multiple bioprinters

My Post - 2021-04-12T220523.125.png

The current drug-discovery process:

  • takes up to 20 years

  • costs $1.3-1.7 billion

  • has an 8% success rate

Axolotl Bioscience's TissuePrint is the solution through its reproducible neurobioink, versatile usability, and compatibility to patient's cells.

TissuePrint is a fibrin-based bioink which supports multiple different cell lines such as patient-derived human-induced pluripotent stem cells (hiPSCs), neural progenitor cells (NPCs), and mesenchymal stem cells (MSCs).

Our novel bioink is compatible with extrusion-based bioprinters from the likes of Cellink, Aspect Biosciences, and Allevi3D.

My Post - 2021-04-13T104115.039.png

TissuePrint is a research-grade bioink, which generates stable and reproducible 3D-structures that can remain in culture for over a month. Not only does neurobioink allow for long-term culture but it also allows cells to maintain high viability and promotes neuronal differentiation.

My Post - 2021-04-13T110553.485.png
bottom of page